Amgen cuts 25% of staff at Kendall Square location

Amgen will lay off a quarter of its staff in Cambridge, Mass., and halt all neuroscience research, according to the Boston Business Journal.

The company said in a state Worker Adjustment and Retraining Notification note Nov. 8 that it will cut 149 people at its research facility in Kendall Square. The move comes just a few years after the company expanded to New England from its headquarters in Thousand Oaks, Calif. 

Amgen will consolidate the rest of its U.S.-based research work at its Thousand Oaks headquarters and San Francisco offices. A spokesperson did not immediately say what would happen to the rest of the Cambridge-based employees, according to the Boston Business Journal. 

The decision comes around the same time the company acquired a 20 percent stake in Chinese drugmaker BeiGene for $2.7 billion. 

Read the full article here

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars